CAS STNext®

CAS STNext® is the premier scientific IP information platform, connecting you to a comprehensive collection of global databases, scientist-curated content, and patent information with powerful precision search and analysis tools. 
 

CAS STNext® is the premier scientific IP information platform, connecting you to a comprehensive collection of global databases, scientist-curated content, and patent information with powerful precision search and analysis tools. 
 

STNext Gradient

Power Your IP Search

Discover the most up-to-date and complete collection of patent and non-patent scientific and technical content.

Find New Connections

Search with confidence by taking advantage of data aggregated, analyzed, and curated by scientists.

Fuel Innovation

 

Leverage efficient workflows to navigate growing data volumes and uncover new insights faster.

CAS STNext delivers complete, trustworthy results. I feel confident that I am capturing as much search scope as possible to make informed decisions about our products.

Patent attorney
Medium enterprise pharmaceuticals company

Source: TechValidate. TVID: 7C0-370-EBA

Resources

Whitepapers

RNA-Derived Medicines: A review of the research trends and developments

The use of RNA in therapeutics has the potential to revolutionize medicine. This white paper highlights emerging trends in targets, chemical modifications, and new delivery systems that increase stability of RNA.

Case Studies

CAS Partnership with INPI Brazil Demonstrates AI Success in Increasing Examiner Productivity​

New artificial intelligence-enabled solution from CAS transforms patent office workflow, cuts examination times in half, speeds customer service, and reduces patent backlogs.

Whitepapers

Bio-based Polymers: A Green Alternative to Traditional Plastics

Read our white paper to find out more about the advantages, limitations, and popularity of the different classes of biopolymers, and how the research and development interest in these alternatives to traditional plastic has changed over the last two decades.